<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Lung Injuries Associated with Scapular Fractures in Adult Traumatic Patients
2
Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass
3
Lung injury and mortality with hyperoxia are increased in Peroxiredoxin 6 gene-targeted mice
4
Lung injury and the cinnamon challenge: college students should beware this Internet dare
5
Lung injury associated with inhalation of effective microorganism blends
6
Lung Involvement in Gaucher Disease
7
Lung involvement in inflammatory bowel diseases
8
Lung ischemia during cardiopulmonary bypass
9
Lung Large Cell Carcinoma Producing Granulocyte-Colony-Stimulating Factor
10
Lung Lesions Biopsy in Children by Computed Tomography (CT) Fluoroscopy Guided Versus Conventional CT Scan Guided
11
Lung membrane diffusing capacity, heart failure, and heart transplantation
12
Lung Nodule Image Classification Based on Local Difference Pattern and Combined Classifier
13
Lung oxidative response after acute coal dust exposure
14
Lung pathology of fatal severe acute respiratory syndrome
15
Lung Perfusion Imaging in Tetralogy of Fallot: A Case Report
16
Lung Perfusion Imaging with Technetium-99m Macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome
17
Lung Perfusion SPECT: Application in a Patient With Tetralogy of Fallot and Suspected Pulmonary Thromboemboli
18
Lung Perfusion With Clarithromycin Ameliorates Lung Function After Cardiopulmonary Bypass
19
Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot
20
Lung Point Sign in Ultrasound Diagnostics of Pneumothorax: Imitations and Variants
21
Lung poly (ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat
22
Lung preservation
23
Lung preservation threshold in a compromised septic lung injury model
24
Lung preservation: The importance of endothelial and alveolar type II cell integrity
25
Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy
26
Lung protection strategy as an effective treatment in acute respiratory distress syndrome
27
Lung Recruitment in Trauma Patients
28
Lung reduction as bridge to lung transplantation in pulmonary emphysema
29
Lung Reduction Operation and Resection of Pulmonary Nodules in Patients With Severe Emphysema
30
Lung resection for non–small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population
31
Lung resection in patients with compromised pulmonary function
32
Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP
33
Lung Resuscitation with Perfluorocarbons Vapor: A Future Outlook
34
Lung retransplantation in children
35
Lung scan in the diagnosis and management of patent foramen ovale (pulmonary embolism, paradoxical embolism)
36
Lung scintigraphy in the diagnosis and follow-up of pulmonary thromboembolism in children with nephrotic syndrome
37
Lung Segmentation using Active Shape Model to Detect the Disease from Chest Radiography
38
Lung stem cells: New paradigms
39
Lung surfactant proteins involved in innate immunity
40
Lung thallium imaging in coronary transplant arteriopathy: “Ce n’est pas un pipe”, ,
41
Lung transplant patients and childhood abuse: A preliminary report
42
Lung transplantation
43
Lung Transplantation
44
Lung transplantation after previous thoracic surgical procedures
45
Lung transplantation and life extension in children with cystic fibrosis Original Research Article
46
Lung Transplantation for Chronic Humidifier Disinfectant-Associated Lung Injury
47
Lung transplantation for congenital pulmonary vein stenosis
48
Lung transplantation for COPD: one lung, two lungs, or none?
49
Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group
50
Lung Transplantation for Idiopathic Pulmonary Fibrosis
51
Lung transplantation for primary and secondary pulmonary hypertension
52
Lung Transplantation for Primary Pulmonary Hypertension and Giant Pulmonary Artery Aneurysm
53
Lung transplantation for pulmonary vascular disease
54
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease
55
Lung transplantation in bronchiolitis obliterans associated with vegetable consumption
56
Lung Transplantation in Children and Young Adults With Cardiovascular Disease
57
Lung Transplantation in Patients 60 Years and Older: Results, Complications, and Outcomes
58
Lung transplantation is warranted for stable, ventilator-dependent recipients
59
Lung transplantation still hampered by chronic rejection
60
Lung transplantation: how to perform the venous anastomosis when clamping is too distal
61
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
62
Lung tumors in 2 year old strain A/J mice exposed for 6 months to tobacco smoke
63
Lung Ultrasonography to Diagnose Bronchopulmonary Dysplasia of Premature Infants
64
Lung Ultrasound (in the Critically Ill) Superior to CT: the Example of Lung Sliding
65
Lung Ultrasound Abnormalities in Patients Without Pulmonary Pathology Prior to Surgery
66
Lung ultrasound and bioimpedance in assessment of volume status of hemodialysis patients
67
Lung Ultrasound Assisted Comparison of Volume Effects of Fluid Replacement Regimens in Pediatric Patients Undergoing Penile Hypospadias Repair: A Randomized Controlled Trial
68
Lung Ultrasound Diagnostic Accuracy in Neonatal Pneumothorax
69
Lung Ultrasound Findings Compared to Chest CT Scan in Patients with COVID-19 Associated Pneumonia: A Pilot Study
70
Lung Ultrasound in Critically Ill Patients
71
Lung Ultrasound in the Critically Ill
72
Lung Ultrasound Is Accurate for the Diagnosis of High-Altitude Pulmonary Edema: A Prospective Study
73
Lung Ultrasound Score to Predict Surfactant Administration in Premature Neonates with Respiratory Distress Syndrome: A Systematic Review and Meta-analysis
74
Lung Ultrasound Scores Predict the Respiratory Support Needs of Late Preterm and Term Neonates with Transient Tachypnea
75
Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation
76
Lung Volume Reduction Reoperations
77
Lung Volume Reduction Surgery Allows Esophageal Tumor Resection in Selected Esophageal Carcinoma With Severe Emphysema
78
Lung Volume Reduction Surgery for a Professional Athlete With Swyer-James Syndrome
79
Lung volume reduction surgery in a ventilated patient with severe pulmonary emphysema
80
Lung volume reduction surgery in emphysema: a systematic review
81
Lung Volume Reduction Surgery in Patients With Emphysema and α-1 Antitrypsin Deficiency
82
Lung volume reduction surgery: a quality operation?
83
Lung volume reduction surgery: An overview
84
Lung volume reduction surgery: Edited by Michael R. Argenziano, MD, and Mark E. Ginsburg, MD, 2001, Totowa, New Jersey, Humana press, 273 pp, illustrated, $145.00, isbn: 0-89603-848-3
85
Lung volume reduction surgery: Lessons learned
86
Lung water, hemodynamics and dyspnea before and after valvuloplasty in mitral stenosis
87
Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax
88
Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy
89
Lunge performance and its determinants
90
Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure
91
Lungmen ABWR containment analyses during short-term main steam line break LOCA using GOTHIC
92
Lung-reduction surgery: 5 years on
93
Lungs is just for breathin’
94
Lung-volume reduction
95
Lung-volume reduction
96
Lung-Volume Reduction Surgery as an Alternative or Bridging Procedure to Lung Transplantation
97
Lungworm infection and ovine visna–maedi: Real risk factor or a confounding variable?
98
L-uniform spaces versus -uniform spaces
99
Lunisolar torque on the atmosphere and Earthʹs rotation
100
Lunotriquetral Ligament Repair Using Augmented Internal Brace
101
Lunz flora in the Austrian Alps — a standard for Carnian floras
102
LUPA: A European initiative taking advantage of the canine genome architecture for unravelling complex disorders in both human and dogs
103
Lupane triterpenes and derivatives with antiviral activity
104
Lupane-Type Triterpenoids Derivatives from Resin of the Socotra Dragon Tree Dracaena cinnabari Balf
105
Lupeol attenuated the NAFLD and PCOS-induced metabolic, oxidative, hormonal, histopathological, and molecular injuries in mice
106
Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes
107
Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene
108
Lupeol: Connotations for chemoprevention
109
Lupin
110
Lupin (Lupinus angustifolius), cowpea (Vigna unguiculata) and navy bean (Phaseolus vulgaris) seeds as supplements for sheep fed low quality roughage
111
Lupin flour addition to wheat flour doughs and effect on rheological properties
112
Lupin flour anaphylaxis
113
LUPIN, a new instrument for pulsed neutron fields
114
LUPIN, a new instrument for pulsed neutron fields
115
Lupin, soya and triticale addition to wheat flour doughs and their effect on rheological properties
116
Lupine protein hydrolysates inhibit enzymes involved in the inflammatory pathway
117
LUPINMOD: A simulation model for the white lupin crop
118
Lupins (L. luteus, L. albus, L. angustifolius) as a protein source for young pigs
119
Lupinus albus plants acquire mercury tolerance when inoculated with an Hg-resistant Bradyrhizobium strain
120
Lupinus angustifolius protein isolates: chemical composition, functional properties and protein characterization
121
Lupinus luteus cv. Wodjil takes up more phosphorus and cadmium than Lupinus angustifolius cv. Kalya
122
Lupinus luteus Pathogenesis-Related Protein as a Reservoir for Cytokinin
123
Lupinus luteus, Vicia sativa and Lathyrus cicera as protein sources for piglets: ileal and total tract apparent digestibility of amino acids and antigenic effects
124
LuPO4:Nd and YPO4:Nd—new promising VUV scintillation materials
125
LuPO4:Nd and YPO4:Nd—new promising VUV scintillation materials
126
Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases
127
Lupron-induced mania
128
LUPS—A language for updating logic programs Original Research Article
129
Lupus anticoagulant and heparin-associated bleeding
130
LUPUS ANTICOAGULANT IN NIGERIAN CHILDREN WITH HOMOZYGOUS SICKLE CELL DISEASE
131
Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: A preliminary report
132
Lupus catatonia in a young girl who presented with fever and altered sensorium
133
Lupus Cystitis in an Omani Girl
134
Lupus Erythematosus and Chronic Granulomatous Disease: Report of Four Iranian Patients with ARCGD and One XLCGD
135
Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndrome
136
Lupus erythematosus panniculitis: a case report
137
Lupus erythematosus panniculitis: A case report
138
Lupus erythematosus: systemic and cutaneous manifestations
139
Lupus erythematosus: uncommon presentations
140
Lupus et troubles psychiatriques : du diagnostic étiologique au traitement
141
Lupus et virus d Epstein-Barr
142
Lupus Headaches in 55 Childhood-Onset SLE
143
Lupus hepatitis: An under-recognized disease feature associated with autoantibodies to ribosomal P
144
Lupus mastitis
145
Lupus miliaris disseminatus faciei: A case report
146
Lupus mortality in Japan
147
Lupus Nephritis in a 2.5 Year Old Girl- An Uncommon Presentation
148
Lupus Nephritis in a Patient with Past History of Henoch Schönlein Purpura
149
Lupus nephritis in pregnancy; a mini-review to current knowledge
150
Lupus Nephritis in Senegal: A Study of 42 Cases
151
Lupus Vulgaris of the Pinna-A Case Report
152
Lupus, still a mystery: A comparison of clinical features of Pakistani population living in suburbs of Karachi with other Asian countries
153
Lupus: Molecular and Cellular Pathogenesis. Edited by G. M. Kammer and G. C. Tsokos
154
Lupus-associated pancreatitis
155
Lupus-like presentation of parvovirus b19 infection
156
Lupus-like syndrome associated with simvastatin
157
Lur’e feedback systems with both unbounded control and observation: Well-posedness and stability using nonlinear semigroups Original Research Article
158
Lurching towards markets for power: China’s electricity policy 1985–2007
159
Lurʹe systems with multilayer perceptron and recurrent neural networks: absolute stability and dissipativity
160
Luria: a Unitary View of Human Brain and Mind
161
Luria-Delbrück Fluctuation Experiments; Accounting Simultaneously for Plating Efficiency and Differential Growth Rate
162
Lurking in the shadows: the informal sector and government policy
163
Lüroth field extensions
164
LURR and the San Simeon M 6.5 Earthquake in 2003 and the Seismic Tendency in CA
165
LURRʹs Twenty Years and its Perspective
166
Lüscher formula for GKP string Original Research Article
167
Lüscherʹs μ-term and finite volume bootstrap principle for scattering states and form factors Original Research Article
168
LUSE, a decision support system for exploration of rural land use allocation: Application to the Terra Chá district of Galicia (N.W. Spain)
169
LUSH Shapes Up for a Starring Role in Olfaction
170
Lushness, numerical index one and duality
171
Lusifer: a LUcid approach to SIx-FERmion production Original Research Article
172
Lusins theorem on fuzzy measure spaces
173
Lusinʹs theorem on fuzzy measure spaces
174
Lusinʹs theorem on monotone measure spaces
175
Lusternik, Schnirelman for subspaces
176
Lusternik-Schnirelmann category and knot complement II
177
Lusternik–Schnirelmann category of a sphere-bundle over a sphere
178
Lusternik–Schnirelmann category of non-simply connected compact simple Lie groups
179
Lusternik–Schnirelmann -category of non-simply connected simple Lie groups
180
Lusternik–Schnirelmann category of skeleta
181
Lustration, Decommunisation and the Rule of Law
182
Lusztig limit of quantum image at root of unity and fusion of image Virasoro logarithmic minimal models Original Research Article
183
Lusztigʹs Canonical Quotient and Generalized Duality
184
Lusztigʹs isomorphism theorem for cellular algebras
185
Lusztigʹs q-analogue of weight multiplicity and one-dimensional sums for affine root systems
186
LUT Filters for Quantized Processing of Signals
187
Luteal activity of Abadeh ecotype does in summer and winter and the effect of kisspeptin-10 on luteinizing hormone secretion in the anestrus does
188
Luteal blood flow and progesterone production in mares
189
Luteal function induced by transvaginal ultrasonic-guided follicular aspiration in mares
190
Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder
191
Luteal phase estradiol versus luteal phase GnRH antagonist administration: their effects on antral follicular size coordination and basal hormonal levels
192
Luteal Phase Progesterone Supplementation in ICSI Cycles: What is the Best Timing?
193
Luteal phase support in assisted reproduction Comment by: Bulent Urman, M.D.Baris Ata, M.D
194
Luteal phase support in assisted reproduction Comment by: Hesham Al Inany, M.D.
195
Luteal phase support in assisted reproduction Comment by: Mohamed Yehia, MD, FRCOG
196
Luteal phase support in assisted reproduction:United Kingdom survey
197
Luteal phase support in in-vitro fertilization
198
Luteal Phase Support in the Intrauterine Insemination (IUI) Cycles: A Randomized Double Blind, Placebo Controlled Study.
199
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase
200
Luteal support of pregnancy in red deer (Cervus elaphus): effect of cloprostenol, ovariectomy and lutectomy on the viability of the post-implantation embryo
201
Luteal vascular perfusion and plasma progesterone concentration are not affected by the vascularity of preovulatory follicle
202
Luteal-phase support in assisted reproductive technology: An ongoing challenge
203
Lutein and Zeaxanthin as Protectors of Lipid Membranes against Oxidative Damage: The Structural Aspects
204
Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk
205
Lutein bioavailability from lutein ester-fortified fermented milk: in vivo and in vitro study
206
Lutein content of selected Indian vegetables and vegetable oils determined by HPLC
207
Lutein content of selected Indian vegetables and vegetable oils determined by HPLC
208
Lutein effect on retina and hippocampus of diabetic mice
209
Lutein extends the lifespan of Drosophila melanogaster
210
Lutein in selected Canadian crops and agri-food processing by-products and purification by high-speed counter-current chromatography
211
Lutein may help reduce atherosclerosis
212
Lutein recovery from Chlorella sp. ESP-6 with coagulants
213
Lutein with various therapeutic activities based on micro and nanoformulations: A systematic mini-review
214
Lutein, but not α-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study
215
Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species
216
Lutein, Zeaxanthin, and the Macular Pigment
217
Lutein, zeaxanthin, macular pigment, and viual function in adult cytic fibroi patient
218
Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood
219
Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood
220
Lutein-enriched frankfurter-type products: Physicochemical characteristics and lutein in vitro bioaccessibility
221
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: Current role and future perspectives
222
Luteinizing hormone (LH) isoforms in ruminants: Characterization and physiological relevance
223
Luteinizing hormone (LH) levels in male workers exposed to urban stressors Original Research Article
224
Luteinizing Hormone and Follicle-Stimulating Hormone Exhibit Different Secretion Patterns from Cultured Madin-Darby Canine Kidney Cells
225
Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
226
Luteinizing Hormone Receptor Formation in Cumulus Cells Surrounding Porcine Oocytes and Its Role During Meiotic Maturation of Porcine Oocytes
227
Luteinizing Hormone Receptor-Mediated Effects on Initiation of Spermatogenesis in Gonadotropin-Deficient (hpg) Mice Are Replicated by Testosterone
228
Luteinizing hormone receptors on granulosa cells from preovulatory follicles and luteal cells throughout the oestrous cycle of pigs
229
Luteinizing hormone secretion as affected by hypophyseal stalk transection and estradiol-17β in ovariectomized gilts
230
Luteinizing hormone secretion as influenced by age and estradiol in the prepubertal gilt
231
Lutembacher’s Syndrome Associated with Meningioma
232
Lutembacher’s Syndrome Associated with Meningioma
233
Luteoforol, a flavan 4-ol, is induced in pome fruits by prohexadione-calciumand shows phytoalexin-like properties against Erwinia amylovoraand other plant pathogens
234
Luteogenesis in Cyclic Ewes: Echotextural, Histological, and Functional Correlates
235
Luteogenic and luteotropic effects of eCG during pregnancy in the mare
236
Luteolin and luteolin-7-O-glucoside strengthen antioxidative potential through the modulation of Nrf2/MAPK mediated HO-1 signaling cascade in RAW 264.7 cells
237
Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFκB pathways in mice with endotoxin-induced acute lung injury
238
Luteolin Co-treatment abates Polystyrene Microplastics (PS-MPs) Induced Spermatotoxicity and Dysgonadogenesis in Rats Via up-regulation of Gonadotropin, Enhanced Spermatogenesis, Downregulation of Caspases, and Oxido-inflammation
239
Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation
240
Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes
241
Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells
242
Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells
243
Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathway
244
Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia
245
Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells
246
Luteolin Reduced the Traumatic Brain Injury-Induced Memory Impairments in Rats: Attenuating Oxidative Stress and Dark Neurons of Hippocampus
247
Luteolin reversed anxiety and depressive-like behavior via modulation of the NF-κB/NLRP3 inflammasome axis in the hippocampus of rats subjected to sleep deprivation
248
Luteolin sensitises drug-resistant human breast cancer cells to tamoxifen via the inhibition of cyclin E2 expression
249
Luteolin suppresses IL-1β-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982
250
Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells
251
Luteolin-inhibited arylamine N-acetyltransferase activity and DNA–2-aminofluorene adduct in human and mouse leukemia cells
252
Luteolysis Induced by a Prostaglandin F2(alpha) Analogue Occurs Independently of Prolactin in the Rat1
253
Luteolysis, estrus induction, and clinical side effects in mares treated with a PDF2α analog, cloprostenol (Sinocrel 11-21)
254
Luteotrophic effect, growth and survival of whole versus half embryos and, their relationship with plasma progesterone concentrations of recipient dairy heifers
255
Luteotropic Hormone Receptors in the Ovary of the Mink (Mustela vison) during Delayed Implantation and Early-Postimplantation Gestation
256
Lutetia surface reconstruction and uncertainty analysis
257
Lutetia׳s lineaments
258
Lutetian magnetostratigraphic calibration of larger foraminifera zonation (SBZ) in the Southern Pyrenees: The Isuela section
259
Lutetian Schizaster Fauna (Echinoidea, Spatangoida) from Sargaz Area, South of Kerman, Iran
260
Lutetium gets a crown: Synthesis, structure and reaction chemistry of the separated ion pair complex, [Li(12-crown-4)2][(C5Me5)2LuMe2]
261
Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundu angiography and photodynamic therapy
262
Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System
263
Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
264
Luting of ceramic inlays in vitro: Marginal quality of self-etch and etch-and-rinse adhesives versus self-etch cements
265
Lütschine fan delta response to climate variability and land use in the Bernese Alps during the last 2400 years
266
Lutte contre le cancer du pancréas exocrine: stagnation ou progrès ? Le point de vue de la Fondation française de cancérologie digestive (FFCD)
267
Lutter contre le tabagisme pour réduire lʹincidence du cancer bronchique: application de la loi ةvin en France
268
Luttinger liquid theory as a model of the gigahertz electrical properties of carbon nanotubes
269
Luttinger liquid theory as a model of the gigahertz electrical properties of carbon nanotubes
270
Luttinger liquids with boundaries: Power-laws and energy scales
271
Lutzomyia (Pintomyia) fischeri (Diptera: Psychodidae: Phlebotominae), a probable vector of American Cutaneous Leishmaniasis: Detection of natural infection by Leishmania (Viannia) DNA in specimens from the municipality of Porto Alegre (RS), Brazil, using
272
Lutzomyia longipalpis spatial distribution and association with environmental variables in an urban focus of visceral leishmaniasis, Misiones, Argentina
273
Lutzomyia migonei as putative vector of visceral leishmaniasis in La Banda, Argentina
274
LUTZOMYIA NUNEZTOVARI ANGLESI (LE FONT & DESJEUX, 1984) AS A VECTOR OF LEISHMANIA AMAZONENSIS IN A SUB-ANDEAN LEISHMANIASIS FOCUS OF BOLIVIA
275
Lutzomyia nuneztovari anglesi (Diptera: Psychodidae) as a probable vector of Leishmania braziliensis in the Yungas, Bolivia
276
LUVIMS lunar UV and IR mapping spectrometer
277
Luxatio erecta of bilateral shoulders
278
Luxatio erecta: A rarely seen, but often missed shoulder dislocation
279
Luxembourg: medicine at the European Court of Justice
280
Lux-Flood basicity of binary silicate melts Original Research Article
281
LUXSim: A component-centric approach to low-background simulations
282
LUXSim: A component-centric approach to low-background simulations
283
Luxury accommodations: the expanding role of structural plasticity in protein–protein interactions
284
LUXURY AND WEALTH∗
285
LUXURY CONSUMPTION, CULTURAL POLITICS, AND THE CAREER OF THE EARL OF ARLINGTON, 1660–1685
286
Luxury Expenses of Shadow Education: A Comparative Study of Iranian Students, Parents and Teachers’ Views
287
Luxury sustainable tourism in Small Island Developing States surrounded by coral reefs
288
Luxury Tourism as a Community Economic Development Strategy in the Depleted Community of Gananoque and the 1000 Islands
289
Luxury uptake of phosphorus by sediment bacteria
290
Luzenac retains strong position in world talc markets, despite growth in Chinese output
291
Luzin measurability of Carathéodory type mappings
292
LuHf geochronology applied to dating Cenozoic events affecting lower crustal xenoliths from Kilbourne Hole, New Mexico
293
LV Dyssynchrony Assessed With Phase Analysis on Gated Myocardial Perfusion SPECT Can Predict Response to CRT in Patients With End-Stage Heart Failure
294
LV remodelling and LVH regression are related to ambulatory (not casual) BP control in hypertension
295
LV/LP CMOS Four-Quadrant Analog Multiplier Cell in Modified Bridged-Triode Scheme
296
LVAD Power Delivery: A Percutaneous Approach to Avoid Infection
297
LVAD support in patients with bioprosthetic valves
298
l-Valine derived benzimidazole based bis-urea in enantioselective fluorescence sensing of L-tartrate
299
l-Valinol and l-phenylalaninol-derived 2-imidazolidinones as chiral auxiliaries in asymmetric aldol reactions
300
L-valued Fuzzy Rough Sets
301
L-valued propositional logic Lvpl
302
LVEF Relation to Depression in Coronary Patients
303
LVMSR: an efficient algorithm to multicast layered video
304
LVOT pseudoaneurysm: A late complication of extended aortic root replacement
305
LV-powered coronary sinus retroperfusion reduces infarct size in acutely ischemic pigs
306
LVQ based speed adaptive swing and stance phase detection: An alternate to Foot Switch
307
L-VRAP—A lunar volatile resources analysis package for lunar exploration
308
Lw*wc AND Rw*wc AND WEAK AMENABILITY OF BANACH ALGEBRAS
309
LW^*W-PROPERTY AND TOPOLOGICAL CENTERS OF BANACH ALGEBRAS
310
Lِwdin population analysis is not rotationally invariant
311
L-weakly and M-weakly compact operators
312
LWIR/SWIR switchable two color device based on InP/InGaAs integrated HBT/QWIP
313
LWR aerosol experiments at victoria model containment
314
LWR containment aerosol experiments at Victoria facility
315
LWR severe accident simulation: Iodine behaviour in FPT2 experiment and advances on containment iodine chemistry
316
LWR spent fuel transmutation in a high power density fusion reactor
317
LWR1 and LWR2 Are Required for Osmoregulation and Osmotic Adjustment in Arabidopsis
318
LWR-PROTEUS Verification of Reaction Rate Distributions in Modern 10 × 10 Boiling Water Reactor Fuel
319
LWRsevereaccidentsimulation:synthesisoftheresultsandinterpretationofthefirstPhebusFPexperimentFPT0OriginalResearchArticle
320
Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo
321
LXII Edward Jackon Lecture: Open Angle Glaucoma After Vitrectomy
322
LXIII Edward Jackon Memorial Lecture: Eye Care: Dollar and ene Original Reearch Article
323
lxodes scapularis: Effects of Repeated Infestations with Pathogen-Free Nymphs on Macrophage and T Lymphocyte Cytokine Responses of BALB/c and C3H/HeN Mice
324
LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response
325
l-Xylose and l-lyxose production from xylitol using Alcaligenes 701B strain and immobilized l-rhamnose isomerase enzyme
326
L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells
327
Ly- (alpha) photon induced amorphization of Ic water ice at 16 Kelvin Effects and quantitative comparison with ion irradiation
328
Ly@Pluto
329
Ly1−(CD5−) B Cells Produce Interleukin (IL)-10
330
LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells
331
LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family
332
LY294002-Mediated Inhibition of Phosphatidylinositol 3-Kinase Activity Triggers Growth Inhibition and Apoptosis in CD40-Triggered Ramos–Burkitt Lymphoma B Cells
333
Ly316340: A potent HIV-1 protease inhibitor containing a high affinity octahydrothienopyridine hydroxyethylamine isostere
334
Ly-6 ligands remain elusive
335
Ly-6 ligands remain elusive
336
LY6A/E (SCA-1) Expression in the Mouse Testis
337
Lyap: A fortran 90 program to compute the Lyapunov exponents of a dynamical system from a time series Original Research Article
338
Lyapunov analysis of the approximate motion equations of flexible structures
339
Lyapunov and feedback characterizations of state constrained controllability and stabilization
340
Lyapunov and marginal instability in Hamiltonian systems
341
Lyapunov and Riccati equations of discrete-time descriptor systems
342
Lyapunov and Wirtinger inequalities Original Research Article
343
Lyapunov characteristic exponents in the generalized photo-gravitational Chermnykh-like problem with power-law profile
344
Lyapunov characterization of forced oscillations
345
Lyapunov conditions for input-to-state stability of impulsive systems
346
Lyapunov conditions for Super Poincaré inequalities
347
Lyapunov control methods of closed quantum systems
348
Lyapunov control of bilinear Schrödinger equations
349
Lyapunov coupled equations for continuous-time infinite Markov jump linear systems
350
Lyapunov criteria for stability in norm of special neutral systems
351
Lyapunov definition and stability of regular or chaotic vibration modes in systems with several equilibrium positions
352
Lyapunov equation for the stability of linear delay systems of retarded and neutral type
353
Lyapunov exponent and almost sure asymptotic stability of quasi-linear gyroscopic systems
354
Lyapunov exponent and entropy of the solar wind flow
355
Lyapunov exponent and stochastic stability of quasi-non-integrable Hamiltonian systems
356
Lyapunov exponent for the parabolic Anderson model in Rd ✩
357
Lyapunov exponent for type-III intermittent chaos
358
Lyapunov exponent in quantum mechanics. A phase-space approach
359
Lyapunov exponent of partial differential equation
360
Lyapunov exponent of random walkers on a bond-disordered lattice
361
Lyapunov exponential stability of 1-D linear hyperbolic systems of balance laws
362
Lyapunov exponents and control sets near singular points
363
Lyapunov exponents and non-equilibrium statistical mechanics
364
Lyapunov Exponents and the Mathematics of Invasion in Oscillatory or Chaotic Populations
365
Lyapunov exponents as a criterion for the dynamic pull-in instability of electrostatically actuated microstructures
366
Lyapunov exponents estimation for hysteretic systems
367
Lyapunov Exponents for 2-D Ray Tracing Without Interfaces
368
Lyapunov exponents for complex systems with delayed feedback
369
Lyapunov exponents for discontinuous dynamical systems of Filip-pov type
370
Lyapunov exponents for solar surface convection
371
Lyapunov exponents from a time series: a noise-robust extraction algorithm
372
Lyapunov exponents in random Boolean networks
373
Lyapunov exponents of free operators
374
Lyapunov exponents of hybrid stochastic heat equations
375
Lyapunov exponents of nilpotent Itô systems with random coefficients
376
Lyapunov exponents of parametrically coupled linear two-DOF stochastic systems and related stability problems
377
Lyapunov exponents of Poisson shot-noise velocity fields
378
Lyapunov exponents of solutions to linear differential equations with periodic forcing functions
379
Lyapunov Exponents versus Expansivity and Sensitivity in Cellular Automata
380
Lyapunov exponents/probabilistic neural networks for analysis of EEG signals
381
Lyapunov first method for nonholonomic systems with circulatory forces
382
Lyapunov formulation of ISS cyclic-small-gain in continuous-time dynamical networks
383
Lyapunov formulation of the ISS cyclic-small-gain theorem for hybrid dynamical networks
384
Lyapunov formulation of the large-scale, ISS cyclic-small-gain theorem: The discrete-time case
385
Lyapunov function design for finite-time convergence analysis: “Twisting” controller for second-order sliding mode realization
386
Lyapunov function for power systems with transfer conductances: extension of the Invariance principle
387
Lyapunov function of general Lurie systems with multiple nonlinearities Original Research Article
388
Lyapunov function, parameter estimation, synchronization and chaotic cryptography
389
Lyapunov Functional for Multiple Delay General Lurie Systems with Multiple Non-linearities1
390
Lyapunov Functionals and Stability for FitzHugh–Nagumo Systems
391
Lyapunov functionals in complex /spl mu/ analysis
392
Lyapunov functionals vs Lyapunov functions for various types of stability of hybrid stochastic differential equation
393
Lyapunov functions and gain bounds for systems with slope restricted nonlinearities
394
Lyapunov functions and global stability for SIR, SIRS, and SIS epidemiological models Original Research Article
395
Lyapunov functions as a measure of biodiversity: theoretical background
396
Lyapunov functions for fractional order systems
397
Lyapunov Functions for Infinite-Dimensional Systems
398
Lyapunov functions for quasi-Hamiltonian systems
399
Lyapunov Functions for Second-Order Differential Inclusions: A Viability Approach
400
Lyapunov functions for SIR and SIRS epidemic models
401
Lyapunov functions for stable cascades and applications to global stabilization
402
Lyapunov functions for strong exponential dichotomies
403
Lyapunov Functions for the Global Stability of Competing Predators
404
Lyapunov functions for the multivariable Popov criterion with indefinite multipliers
405
Lyapunov functions for time-relevant systems, with application to first-orthant stable systems
406
Lyapunov functions for trichotomies with growth rates
407
Lyapunov functions method in the problem of nonlinear control system design (control of blackbox of mechanical nature) Original Research Article
408
Lyapunov hydrodynamics in the dilute limit
409
Lyapunov inequalities for discrete linear Hamiltonian systems
410
Lyapunov inequalities for partial differential equations
411
Lyapunov inequalities for the periodic boundary value problem at higher eigenvalues
412
Lyapunov inequality and bounded real lemma for discrete-time descriptor systems
413
Lyapunov inequality for a class of fractional differential equations with Dirichlet boundary conditions
414
Lyapunov inequality for linear Hamiltonian systems on time scales
415
Lyapunov instability in the extended XY-model: Equilibrium and nonequilibrium molecular dynamics simulations
416
Lyapunov instability, local curvature, and the fluid-solid phase transition in two-dimensional particle systems
417
Lyapunov iteration and equation characterizations for unobservable subspace
418
Lyapunov matrices for a class of time delay systems
419
Lyapunov matrices for time-delay systems
420
Lyapunov matrices: Existence and uniqueness issues
421
Lyapunov method for the stability of fluid networks
422
Lyapunov operator inequalities for exponential stability of Banach space semigroups of operators
423
Lyapunov optimization of a damped system
424
Lyapunov pairs for continuous perturbations of nonlinear evolutions Original Research Article
425
Lyapunov pairs for multi-valued semi-linear evolutions Original Research Article
426
Lyapunov regularity of impulsive differential equations
427
Lyapunov sequences for exponential trichotomies Original Research Article
428
Lyapunov spectra and nonequilibrium ensembles equivalence in 2D fluid mechanics
429
Lyapunov spectrum of a lattice of chaotic systems with local and non-local couplings
430
Lyapunov stability analysis for nonlinear delay systems
431
Lyapunov stability control of inverted pendulums with general base point motion
432
Lyapunov stability for a class of predator–prey model with delayed nutrient recycling
433
Lyapunov stability for an age-structured population model
434
Lyapunov stability for an age-structured population model
435
Lyapunov stability of a class of hybrid dynamic systems
436
Lyapunov stability of elliptic periodic solutions of nonlinear damped equations
437
Lyapunov stability of systems of lineargeneralized ordinary differential equations
438
Lyapunov stability theorem about fractional system without and with delay
439
Lyapunov stability using minimum distance control Original Research Article
440
Lyapunov stability, regions of attraction, and indeterminate growth paths
441
Lyapunov theorems for systems described by retarded functional differential equations Original Research Article
442
Lyapunov timescales and black hole binaries
443
Lyapunov tools for predictor feedbacks for delay systems: Inverse optimality and robustness to delay mismatch
444
Lyapunov type equation for discrete exponential trichotomies
445
Lyapunov type inequalities for second-order half-linear differential equations
446
Lyapunov, Lanczos, and inertia Original Research Article
447
Lyapunov/Passivity-Based Adaptive Control of Relative Degree Two MIMO Systems With an Application to Visual Servoing .
448
Lyapunov’s direct method for stabilization of the Furuta pendulum
449
Lyapunov’s inequality on timescales Original Research Article
450
Lyapunov’s theory methods in stability problems of singular systems Original Research Article
451
Lyapunov-based adaptive control of MIMO systems
452
Lyapunov-based adaptive state estimation for a class of nonlinear stochastic systems
453
Lyapunov-Based Approach to Multiagent Systems With Switching Jointly Connected Interconnection
454
Lyapunov-based backward-horizon adaptive stabilization
455
Lyapunov-based continuous-time nonlinear controller redesign for sampled-data implementation
456
Lyapunov-based control for three-phase PWM AC/DC voltage-source converters
457
Lyapunov-based control strategy for power-factor preregulators
458
Lyapunov-based controller design for bounded dynamic stochastic distribution control
459
Lyapunov-based decentralized adaptive control for laser beam tracking systems
460
Lyapunov-based design of locally collocated controllers for semi-linear parabolic PDE systems
461
Lyapunov-Based Distributed Control of Systems on Lattices.
462
Lyapunov-based hybrid loops for stability and performance of continuous-time control systems
463
Lyapunov-based model predictive control of stochastic nonlinear systems
464
Lyapunov-based quantitative analysis of robust stability
465
Lyapunov-Based Robust Power Controllers for a Doubly Fed Induction Generator
466
Lyapunov-based stability analysis automated by genetic programming
467
Lyapunov-based switching control of nonlinear systems using high-gain observers
468
Lyapunov-based switching supervisory control of nonlinear uncertain systems
469
Lyapunov-Based Tracking Control in the Presence of Uncertain Nonlinear Parameterizable Friction
470
Lyapunov-Based Tracking Control of a Bi-Rotor
471
Lyapunov-global-Lanczos algorithm for model order reduction and adaptive PI controller of large-scale electrical systems
472
Lyapunov-Krasovskii Approach for Delay-Dependent Stability Analysis of Nonlinear Time-Delay Systems
473
Lyapunov–Krasovskii approach to the robust stability analysis of time-delay systems
474
Lyapunov–Krasovskii functional for uniform stability of coupled differential-functional equations
475
Lyapunov–Krasovskii functionals and application to input delay compensation for linear time-invariant systems
476
Lyapunov–Krasovskii functionals for scalar neutral type time delay equations
477
Lyapunov–Krasovskii functionals for scalar time delay equations
478
Lyapunov-razumikhin functionals and stability theory in terms of two measures for p-nfde Original Research Article
479
Lyapunov–Razumikhin method for impulsive functional differential equations and applications to the population dynamics
480
Lyapunov–Razumikhin pairs in the instability problem for infinite delay equations Original Research Article
481
Lyapunovʹs approach to analysis, synthesis and robustness of nonlinear systems with delays Original Research Article
482
Lyapunovʹs Second Method for Random Dynamical Systems
483
Lyapunov-Schmidt Method in Bifurcation Solutions of Nonlinear Fourth Order Differential Equation
484
Lyapunov–Schmidt reduction algorithm for three-dimensional discrete vortices
485
Lyapunov-Schmidt Reduction and Melnikov Integrals for Bifurcation of Periodic Solutions in Coupled Oscillators
486
Lyapunov–Schmidt reduction for unfolding heteroclinic networks of equilibria and periodic orbits with tangencies
487
LYAPUNOV-SCHMIDT REDUCTION IN THE STUDY OF PERIODIC TRAVELLING WAVE SOLUTIONS OF NONLINEAR DISPERSIVE LONG WAVE EQUATION
488
Lyapunov-type inequalities for a class of higher-order linear differential equations
489
Lyapunov-type inequalities for a class of higher-order linear differential equations with anti-periodic boundary conditions
490
Lyapunov-type inequalities for certain higher order differential equations with anti-periodic boundary conditions
491
Lyapunov-type inequalities for certain higher order fractional differential equations
492
Lyapunov-type Inequalities for Certain Nonlinear Systems on Time Scales
493
Lyapunov-type inequalities for even order difference equations
494
Lyapunov-type inequalities for fractional quasilinear problems via variational methods
495
Lyapunov-type inequalities for Laplacian systems and applications to boundary value problems
496
Lyapunov-type inequalities for nonlinear systems
497
Lyapunov-type inequality for a class of Dirichlet quasilinear systems involving the -Laplacian
498
Lyapunov-type inequality for a class of odd-order differential equations
499
Lyapunov-type inequality for a class of quasilinear systems
500
Lyase-catalyzed degradation of alginate in the gelled state: Effect of gelling ions and lyase specificity
501
LYCANTHROPY IN DEPRESSION: A CASE REPORT
502
Lychee (Litchi chinensis Sonn.) seed water extract as potential antioxidant and anti-obese natural additive in meat products
503
Lycium Barbarum Polysaccharide Attenuates Acute Toxicity Caused by Titanium Dioxide Nanoparticles in Splenic and Pulmonary Tissues
504
Lycium barbarum polysaccharide inhibits the mitochondrial pathway of apoptosis in mouse bone marrow mononuclear cells after radiation injury
505
Lycium barbarum polysaccharides ameliorates physical fatigue
506
Lycium barbarum polysaccharides as an adjuvant for recombinant vaccine through enhancement of humoral immunity by activating Tfh cells
507
Lycium barbarum polysaccharides as an adjuvant for recombinant vaccine through enhancement of humoral immunity by activating Tfh cells
508
LYCIUM DASYSTEMUM POJARK. (SOLANACEAE), A NEW RECORD FROM IRAN.
509
Lycobelines A–C, Novel C16N2-type Lycopodium alkaloids from Huperzia goebelii
510
Lycochinines A–C, novel C27N3 alkaloids from Lycopodium chinense
511
Lyconadins C and F, new Lycopodium alkaloids from Lycopodium complanatum
512
Lyconesidines A–C, new alkaloids from Lycopodium chinense
513
Lycopanerols H, two high molecular weight ether lipids from Botryococcus braunii comprising an α-tocopherol unit
514
Lycoparins A–C, new alkaloids from Lycopodium casuarinoides inhibiting acetylcholinesterase Original Research Article
515
Lycopene - tomatos secret weapon against oxidative stress
516
Lycopene affects proliferation and apoptosis of four malignant cell lines
517
Lycopene and resveratrol pretreatment did not interfere with the liver of hepatectomized rats
518
Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway
519
Lycopene approved as a food ingredient in the EU
520
Lycopene as A Carotenoid Provides Radioprotectant and Antioxidant Effects by Quenching Radiation-Induced Free Radical Singlet Oxygen: An Overview
521
Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia
522
Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study
523
Lycopene bioavailability
524
Lycopene bioavailability
525
Lycopene colorants approved by the FDA & objections dismissed
526
Lycopene Content of Selected Tomato Based Products, Fruits and Vegetables Consumed In South Western Nigeria
527
Lycopene degradation, isomerization and in vitro bioaccessibility in high pressure homogenized tomato puree containing oil: Effect of additional thermal and high pressure processing
528
Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines
529
Lycopene enrichment of cultured airway epithelial cells decreases the inflammation induced by rhinovirus infection and lipopolysaccharide
530
Lycopene extraction from tomato peel by-product containing tomato seed using supercritical carbon dioxide Original Research Article
531
Lycopene in association with α-tocopherol or tomato lipophilic extracts enhances acyl-platelet-activating factor biosynthesis in endothelial cells during oxidative stress
532
Lycopene in atherosclerosis prevention: An integrated scheme of the potential mechanisms of action from cell culture studies
533
Lycopene in serum, skin and adipose tissues after tomato-oleoresin supplementation in patients undergoing haemorrhoidectomy or peri-anal fistulotomy
534
Lycopene Inhibits DNA Damage and Liver Necrosis in Rats Treated with Ferric Nitrilotriacetate
535
Lycopene inhibits DNA damage and reduces hMTH1 mRNA expression in the liver of Mongolian gerbils treated with ferric nitrilotriacetate
536
Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1
537
Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue
538
Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway
539
Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals
540
Lycopene modulates growth and survival associated genes in prostate cancer
541
Lycopene oxidation product enhances gap junctional communication
542
Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression
543
Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages
544
Lycopene red as a food colorant & antioxidant
545
Lycopene reduces deltamethrin effects induced thyroid toxicity and DNA damage in albino rats
546
Lycopene regulation of cholesterol synthesis and efflux in human macrophages
547
Lycopene solubility in mixtures of carbon dioxide and ethyl acetate
548
Lycopene Stability in Tomato Powders
549
Lycopene Supplementation Enhances Growth Performance, Antioxidant Enzymes, Heat Shock Protein 70, and Some Biochemical and Immune Parameters in Broiler Chickens Exposed to Heat Stress
550
Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains
551
Lycopene: A Biologically Important Carotenoid for Humans?
552
Lycopene: A novel drug therapy in hormone refractory metastatic prostate cancer
553
Lycopene: modes of action to promote prostate health
554
Lycopene-rich fractions derived from pink guava by-product and their potential activity towards hydrogen peroxide-induced cellular and DNA damage
555
Lycopenoids: Are lycopene metabolites bioactive?
556
Lycopersicon esculentum (Tomato) Prevents Adverse Effects of Lead on Blood Constituents
557
Lycopladine A, a new C16N alkaloid from Lycopodium complanatum
558
Lycopladine H, a novel alkaloid with fused-tetracyclic skeleton from Lycopodium complanatum
559
Lycopladines B–D and lyconadin B, new alkaloids from Lycopodium complanatum Original Research Article
560
Lycopladines F and G, new C16N2-type alkaloids with an additional C4N unit from Lycopodium complanatum
561
Lycopodium dust ame characteristics considering char yield
562
Lycopodium spore impacts onto surfaces
563
Lycopsid–arthropod associations and odonatopteran oviposition on Triassic herbaceous Isoetites
564
LycoRed acquires Reisman
565
Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells
566
Lycotetrastine A, a novel hexacyclic alkaloid from Huperzia tetrasticha
567
Lyell syndrome revisited: analysis of 18 cases of severe bullous skin disease in a burns unit
568
Lying about facial recognition: An fMRI study
569
Lying and falsely implicating
570
Lying behavior in horses in relation to box size
571
Lying in Childrenʹs Fiction: Morality and the Imagination: “It is true!” cried the lying Nutcracker. “And what is true is not a lie.”
572
Lying relies on the truth
573
Lying through their teeth: Third party advice and truth telling in a strategy proof mechanism
574
Lying versus refusal for known potential secrets
575
Lying: A Metaphorical Memoir. By Lauren Slater
576
Lyleʹs administration of the college library : 1997 Text Edition, by Caroline M. Coughlin and Alice Gertzog. Lanham, Maryland: Scarecrow, 1997. 187p. $29.50 (paper) ISBN 0- 8108-3330-1. $38.00 (cloth). ISBN 0-8108-3330-6
577
Lyman A. Brewer III (1907–1988): surgeon-scientist, inspirational teacher, and humanist
578
Lyman Break Galaxies and the Ly(alpha) Forest
579
Lyman C Wynne
580
Lyman α intensities in a polar coronal hole from a 2D model Original Research Article
581
Lyman- α photodissociation of CH3CFCl2 (HCFC-141b): Quantum yield and translational energy of hydrogen atoms
582
Lyman-alpha observations of comet 46 P/Wirtanen with swan on SOHO: H2O production rate near 1997 perihelion
583
Lyman-alpha observations of comet Hyakutake with SWAN on SOHO
584
Lymanʹs Law is active in loanwords and nonce words: Evidence from naturalness judgment studies
585
Lyman-α photodissociation of CH3CFCl2 (HCFC-141b): Quantum yield and translational energy of hydrogen atoms
586
Lyme borreliosis
587
Lyme borreliosis
588
Lyme borreliosis
589
Lyme borreliosis
590
Lyme borreliosis mimicking central nervous system malignancy: the diagnostic pitfall of cerebrospinal fluid cytology
591
Lyme borreliosis: A neglected zoonosis in Egypt
592
Lyme borreliosis—an unusual cause of vertigo
593
Lyme Carditis Buried Beneath ST-Segment Elevations
594
Lyme carditis: A rare presentation in an unexpected setting
595
Lyme Carditis: An Interesting Trip to Third-Degree Heart Block and Back
596
Lyme carditis: Persistent local delayed enhancement by cardiac magnetic resonance imaging
597
Lyme disease
598
Lyme disease (Lyme borreliosis)
599
Lyme disease and preventive behaviors in residents of Nantucket Island, Massachusetts Original Research Article
600
Lyme disease and related tick-borne illnesses
601
Lyme Disease in Children
602
Lyme Disease Incidence in Wisconsin: A Comparison of State-reported Rates and Rates from a Population-based Cohort
603
Lyme disease masquerading as brown recluse spider bite
604
Lyme disease presenting as an influenza-like illness
605
Lyme disease presenting as Touretteʹs syndrome
606
Lyme disease surveillance in Maryland, 1992
607
Lyme disease vaccines are safe and effective
608
Lyme disease without erythema migrans: cause for concern?
609
Lyme disease: An active agent in dilated cardiomyopathy?
610
Lyme disease: Current issues, implications, and recommendations for tourism management
611
Lyme disease: scratching the surface
612
Lyme Disease: Self-regulation and Pathogen Invasion
613
Lyme disease—what is the cost for Scotland?
614
Lyme myelitis mimicking neurological malignancy
615
Lyme neuroborreliosis in Great Britain
616
Lyme neuroborreliosis in Great Britain – Authorʹs reply
617
Lyme neuroborreliosis: infection, immunity, and inflammation
618
Lyme Regis in danger
619
Lymph invasion route of bacteria and endotoxin and CD4+/CD8+ T cells ratio changes of draining lymph node of burn infection wound
620
Lymph Node Analysis in Esophageal Resection: American College of Surgeons Oncology Group Z0060 Trial
621
Lymph Node and Bone Marrow Micro-Metastasis in Patients with Esophageal Cancer
622
Lymph node dissection for clinically evident lymph node metastases of malignant melanoma
623
Lymph Node Dissection for Differentiated Thyroid Cancer
624
Lymph Node Enlargement in Neck Filariasis as a Rare Cause: A Case Report
625
Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host
626
Lymph node hemangioma in one-humped camel
627
Lymph node histopathological studies in a combined adjuvant–collagen induced arthritis model in albino rat Rattus rattus
628
Lymph Node Involvement and Related Risk Factors in Patients With Breast Cancer Referred for Radiotherapy: A 20-Year Study on 15 000 Women
629
Lymph Node Metastases in a Pedicled Pericardial Fat Pad Flap
630
Lymph node metastases in gastric cancer invading the submucosal layer
631
Lymph node metastases in hamster tongue cancer induced with 9,10-dimethyl-1,2-benzanthracene: association between histological findings and the incidence of neck metastases, and the clinical implications for patients with tongue cancer
632
Lymph node metastasis from a primary skin carcinoid tumour
633
Lymph Node Metastasis in Gastrointestinal Stromal Tumor (GIST): to Report a Case
634
Lymph node positive head and neck carcinoma after curative radiochemotherapy: A long lasting debate on elective post-therapeutic neck dissections comes to a conclusion
635
Lymph node recurrence of gallbladder carcinoma successfully managed by systemic chemotherapy with 5-fluorouracil and mitomycin C: report of a 5-year survivor
636
LYMPH NODE REVEALING SOLUTION: A PROSPECTIVE STUDY ON 35 PATIENTS WITH COLORECTAL CARCINOMAS
637
Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology
638
Lymph node status and survival in cutaneous malignant melanoma—sentinel lymph node biopsy impact
639
Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer
640
Lymph Node Status in Colorectal Cancer; Is There a Case for Auditing the Pathologist and the Surgeon?
641
lymph node status in colorectal cancer; is there a case for auditing the pathologist and the surgeon?
642
Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma
643
Lymph node vascular-stromal growth and function as a potential target for controlling immunity
644
Lymph transport in the skin
645
Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: Correlation with pathologic parameters and clinical outcome
646
Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: Correlation with pathologic parameters and clinical outcome
647
Lymphadenectomy and pancreatico-splenectomy in gastric cancer surgery
648
Lymphadenectomy and pancreatico-splenectomy in gastric cancer surgery
649
Lymphadenectomy for papillary thyroid cancer: Changes in practice over four decades
650
Lymphadenectomy in bladder cancer: How high is “high enough”?
651
Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications
652
Lymphadenectomy in primary carcinoma of the Fallopian tube
653
Lymphadenopathy in a pregnant woman from Brazil
654
Lymphadenopathy, pneumonia, and HIV—a common trio, an uncommon outcome
655
Lymphangiectasia within angiomyolipoma in a tuberous sclerosis patient
656
Lymphangiogenesis in Odontogenic Keratocysts Compared with Dentigerous Cysts
657
Lymphangiogenesis: Molecular Mechanisms and Future Promise
658
Lymphangiographic study of pelvic adenopathy regression in a phase II trial of methyl-hydroxy-ellipticine in HIV1-AIDS complex
659
Lymphangiohemangioma of the Mediastinum
660
Lymphangioleiomyomatosis initially presenting with abdominal pain: A case report
661
Lymphangioma circumscriptum of the vulva mimicking genital wart: A case report
662
Lymphangioma of the esophagus: Surgical treatment
663
Lymphangioma of the Thoracic Spine with Epidural Compression: A Case Report
664
Lymphangiomatosis Possibly With Gorhamʹs Disease and Not Lymphangioma
665
Lymphangiomatosis Possibly With Gorhamʹs Disease and Not Lymphangioma: Reply
666
Lymphangiomatosis: The Cause of Refractory Pleural Effusion in a Patient with Lupus Erythematosus
667
Lymphangiomatosis: The Cause of Refractory Pleural Effusion in a Patient with Lupus Erythematosus
668
Lymphangiosarcoma. Reports of 3 cases and review of the literature
669
Lymphatic absorption of plasmalogen in rats
670
Lymphatic atlas-based target volume definition for intensity-modulated radiation therapy planning
671
Lymphatic atlas-based target volume definition for intensity-modulated radiation therapy planning
672
Lymphatic compromise associated with substernal goiter
673
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
674
Lymphatic drug delivery: therapy, imaging and nanotechnology
675
Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: A systematic review
676
LYMPHATIC FILARIASIS and THE GLOBAL ELIMINATION PROGRAM
677
Lymphatic filariasis and the women of India
678
Lymphatic Filariasis Presenting as a Swelling over the Upper Arm: A Case Report
679
Lymphatic filariasis related perceptions and practices on the coast of Ghana: implications for prevention and control
680
Lymphatic malformation of the parapharyngeal space
681
Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy
682
Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip
683
Lymphatic mapping and sentinel lymphadenectomy for breast cancer
684
Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers
685
Lymphatic mapping and sentinel node biopsy in gastric cancer
686
Lymphatic mapping and sentinel node biopsy in Merkelʹs cell carcinoma
687
Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery
688
Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer
689
Lymphatic mapping for endometrial cancer: Is hysteroscopic injection a safe technique for sentinel lymph node biopsy?
690
Lymphatic mapping with tracer administration into the primary breast cancer
691
Lymphatic metastasis in head and neck squamous cell carcinoma
692
Lymphatic Microvessel Density and the Expression of Lymphangiogenic Factors in Oral Squamous Cell Carcinoma
693
Lymphatic Microvessel Density Combined with CT Used in the Diagnosis of Mediastinal and Hilar Lymph Node Metastasis of Non-small Cell Lung Cancer
694
Lymphatic organ development in dogs: major lymphocyte subsets and activity
695
Lymphatic organ development in dogs: major lymphocyte subsets and activity
696
Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon
697
Lymphatic targeting with nanoparticulate system
698
Lymphatic targeting with nanoparticulate system
699
Lymphatic transfer studies with immunoglobulin scintigraphy after axillary surgery
700
Lymphatic transport of cholesterol in normocholesterolemic rats treated with pravastatin, an inhibitor of HMG-CoA reductase
701
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
702
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation
703
Lymphatics and adipose tissue
704
Lymphatics and the processing of antigen
705
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
706
Lymphatics in nanophysiology
707
Lymphedema
708
Lymphedema after treatment of breast cancer
709
Lymphedema in a 7-year-old boy infected with Wuchereria bancrofti in Sierra Leone: A case report
710
Lymphedema Management Following Breast Cancer Treatment
711
Lymphedema of the lower extremity as a complication of local burns
712
Lymphedema: another aspect in cutaneous leishmaniasis
713
Lymphedema-ditichiai yndrome and FOXC2 gene mutation
714
Lymphedema-induced lymphangiosarcoma
715
Lymph-node-negative oestrogen-receptor-positive breast cancer
716
Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in 18F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography
717
Lymphoblastoid cell lines of Rett syndrome patients exposed to oxidative-stress-induced apoptosis
718
Lymphoblastoid cell lines: a continuous in vitro source of cells to study carcinogen sensitivity and DNA repair
719
Lymphoblastoid interferon-α downregulates parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor expression in human osteoblastic cells (Saos-2)
720
Lymphoblastoid interferon-α downregulates parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor expression in human osteoblastic cells (Saos-2)
721
Lymphocele After Kidney Transplantation Where Are We Standing Now?
722
Lymphocele Following Renal Transplantation
723
Lymphocele of the thoracic duct presenting as a left supraclavicular mass: a case report and review of the literature
724
Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment
725
Lymphocyte activation
726
Lymphocyte activation
727
Lymphocyte activation
728
Lymphocyte activation
729
Lymphocyte activation
730
Lymphocyte activation and effector functions
731
Lymphocyte activation and effector functions
732
Lymphocyte activation and effector functions How signals are integrated in the immune system
733
Lymphocyte activation and effector functions Multistorey progress: increasing organization on all levels
734
Lymphocyte activation and effector functions Turning lymphocytes on and off
735
Lymphocyte activation and effector functions Web alert
736
Lymphocyte activation and effector functions: Editorial overview
737
Lymphocyte activation and effector functions: In vivo veritas
738
Lymphocyte activation and effector functions: Web alert
739
Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs
740
Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs
741
Lymphocyte Activation in Angina Pectoris
742
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
743
Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens
744
Lymphocyte blastogenic response to ovalbumin in a model for canine allergy
745
Lymphocyte characteristics in children with common variable immunodeficiency
746
Lymphocyte chromosome breakage in low benzene exposure among Indonesian workers
747
Lymphocyte content of amyloid precursor protein is increased in Downʹs syndrome and aging
748
Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects
749
Lymphocyte Cytotoxicity of oxLDL in Patients with Atherosclerosis
750
Lymphocyte development
751
Lymphocyte development
752
Lymphocyte development
753
Lymphocyte development
754
Lymphocyte development
755
Lymphocyte development
756
Lymphocyte development
757
Lymphocyte development Commitment, selection and switching: Editorial overview
758
Lymphocyte development Essential features
759
Lymphocyte development Immunological techniques: Web alert
760
Lymphocyte development in fetal piglets: Facts and surprises
761
Lymphocyte development in fetal piglets: Facts and surprises
762
Lymphocyte Development in Irradiated Thymuses: Dynamics of Colonization by Progenitor Cells and Regeneration of Resident Cells
763
Lymphocyte development The (knock-) ins and outs of lymphoid development
764
Lymphocyte development: Editorial overview
765
Lymphocyte development: overview
766
Lymphocyte development: Regulation of B and T lymphoid cell development
767
Lymphocyte development: Signals that regulate lymphocyte development and differentiation
768
Lymphocyte differentiation in sea bass thymus: CD4 and CD8-α gene expression studies
769
Lymphocyte effector functions: armed for destruction?
770
Lymphocyte effector functions: Integrating new concepts with a deeper understanding of established ones
771
Lymphocyte effector functions: Lymphocyte effector mechanisms in innate and adaptive immunity
772
Lymphocyte effector functions: Lymphocyte heterogeneity — is it limitless?
773
Lymphocyte effector functions: Memory and unique subsets of lymphocytes
774
Lymphocyte expression of CD95 at rest and in response to acute exercise in healthy children and adolescents
775
Lymphocyte G proteins reflect response to treatment in congestive heart failure
776
Lymphocyte GH-axis hormones in immunity
777
Lymphocyte immunophenotype reference ranges in healthy Indian adults: implications for management of HIV/AIDS in India
778
Lymphocyte intracellular free calcium concentration is increased in preeclampsia, ,
779
Lymphocyte kinetics: the interpretation of labelling data
780
Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
781
Lymphocyte lipid rafts: structure and function
782
Lymphocyte measures in treatment-naïve 13–15-year old adolescents with alcohol use disorders
783
Lymphocyte memory and affinity selection
784
Lymphocyte Migration across the Anterior and Posterior Blood–Retinal Barrierin Vitro
785
Lymphocyte migration in the intestinal mucosa: entry, transit and emigration of lymphoid cells and the influence of antigen
786
Lymphocyte migration in the intestinal mucosa: entry, transit and emigration of lymphoid cells and the influence of antigen
787
Lymphocyte Migration Inhibition Response in Trichuris muris In¬fected and Vaccinated Mice
788
Lymphocyte migration into tissue: the paradigm derived from CD4 subsets
789
Lymphocyte phenotyping in untreated children patients with chronic allergic asthma
790
Lymphocyte phospholipid methylation is altered in schizophrenia
791
Lymphocyte populations and adhesion molecule expression in bovine tonsils
792
Lymphocyte populations and adhesion molecule expression in bovine tonsils
793
Lymphocyte populations in dermal lymphoid aggregates of vitiliginous Smyth line and normally pigmented Light Brown Leghorn chickens
794
Lymphocyte populations in dermal lymphoid aggregates of vitiliginous Smyth line and normally pigmented Light Brown Leghorn chickens
795
Lymphocyte populations in tuberculous pleural effusions Clinical usefulness of biochemical resorption markers in osteoporosis
796
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features
797
Lymphocyte Proliferation Assays May Underestimate Antigen Responsiveness in Human Immunodeficiency Virus Infection
798
Lymphocyte proliferation modulated by glutamine: involved in the endogenous Tred ox reaction
799
Lymphocyte propionyl-CoA carboxylase and accumulation of odd-chain fatty acid in plasma and erythrocytes are useful indicators of marginal biotin deficiency☆
800
Lymphocyte recruitment to the liver in alcoholic liver disease
801
Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis
802
Lymphocyte selection by starvation: glucose metabolism and cell death
803
Lymphocyte shedding from genital tract of human immunodeficiency virus-infected women: Immunophenotypic and clinical correlates
804
Lymphocyte signaling in year 1 of the postgenomic era
805
Lymphocyte Subgroups in Pleural Fluid and Peripheral Blood of Tuberculous Pleurisy Patients with Positive and Negative PPD Reactions
806
Lymphocyte Subgroups in Pleural Fluid and Peripheral Blood of Tuberculous Pleurisy Patients with Positive and Negative PPD Reactions
807
Lymphocyte subpopulations and neutrophil function in calves during the first 6 months of life
808
Lymphocyte subpopulations and neutrophil function in calves during the first 6 months of life
809
Lymphocyte subpopulations in blood and duodenal epithelium of broilers fed diets contaminated with deoxynivalenol and zearalenone
810
Lymphocyte Subpopulations in Patients With Acute Brucellosis
811
Lymphocyte subpopulations in the mammary gland of the goat
812
Lymphocyte subpopulations in the mammary gland of the goat
813
Lymphocyte subset abnormalities in canine leishmaniasis
814
Lymphocyte subset abnormalities in canine leishmaniasis
815
Lymphocyte subset abnormalities in German shepherd dog pyoderma (GSP)
816
Lymphocyte subset abnormalities in German shepherd dog pyoderma (GSP)
817
Lymphocyte subset patterns and cytokine production in Alzheimerʹs disease patients
818
Lymphocyte subset proliferative responses of Mycobacterium bovis-infected cattle to purified protein derivative
819
Lymphocyte subset proliferative responses of Mycobacterium bovis-infected cattle to purified protein derivative
820
Lymphocyte Subset Redistribution in Response to Acute Experimental Stress: Effects of Gender, Ethnicity, Hypertension, and the Sympathetic Nervous System
821
Lymphocyte subset, lymphocyte proliferative response, and soluble interleukin-2 receptor in anorexic patients
822
Lymphocyte subsets and adhesion molecule expression in milk and blood of periparturient dairy cattle
823
Lymphocyte subsets and adhesion molecule expression in milk and blood of periparturient dairy cattle
824
Lymphocyte subsets in peripheral blood of dogs — a flow cytometric study
825
Lymphocyte subsets in peripheral blood of dogs — a flow cytometric study
826
Lymphocyte subsets in porcine tonsillar crypt epithelium
827
Lymphocyte subsets in porcine tonsillar crypt epithelium
828
Lymphocyte subsetsʹ reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study
829
Lymphocyte subsets, macrophages and Langerhans cells in actinomycetoma and eumycetoma tissue reaction
830
Lymphocyte T subset counts in children with elevated low-density lipoprotein cholesterol levels Original Research Article
831
Lymphocyte T subsets during dietary therapy in children with hypercholesterolemia
832
Lymphocyte Trafficking in the CNS and Periphery: Relationship to Neural–Immune Interactions
833
Lymphocyte trafficking, survival and proliferation
834
Lymphocyte ultrastructure in patients with multiple sclerosis
835
Lymphocyte-mediated liver injury in alcohol-related hepatitis
836
LYMPHOCYTES DNA CONTENT, P53, C-MYC AND BCL-2 AS PREDICTIVE MARKERS IN CHILDHOOD WITH ACUTE LYMPHOBLASTIC LEUKEMIA
837
Lymphocytes Expressing Fcγ Receptors Suppress Antigen-Induced Proliferation in Cells from Guinea Pigs Infected with VirulentMycobacterium tuberculosis
838
Lymphocytes Expressing α1β1 Integrin (Very Late Antigen-1) in Peripheral Blood of Patients with Arthritis Are a Subset of CD45RO+ T-Cells Primed for Rapid Adhesion to Collagen IV
839
Lymphocytes from one side of the bovine mammary gland migrate to the contra lateral gland and lymph node tissue
840
Lymphocytes from one side of the bovine mammary gland migrate to the contra lateral gland and lymph node tissue
841
Lymphocytes in human atherosclerotic plaque exhibit the elastin-laminin receptor: potential role in atherogenesis Original Research Article
842
Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis
843
Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis
844
Lymphocytes transport serotonin and dopamine: agony or ecstasy?
845
Lymphocytes Utilize CD11b/CD18 for Adhesion toCandida albicans
846
Lymphocytes with T-cell-like properties express the Fas ligand in the Japanese flounder Paralichthys olivaceus
847
Lymphocytes: attackers and targets of the same oncogenic viruses, depending on their immunogenic strength
848
Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines
849
Lymphocyte-Synovial Cell Interactions: A Role for β1 and β3 Integrin-Mediated Adhesion to Cellular Fibronectin
850
Lymphocytic choriomeningiti viru chorioretiniti mimicking ocular toxoplamoi in two otherwie normal children
851
Lymphocytic choriomeningiti viru: an underdiagnoed caue of congenital chorioretiniti
852
Lymphocytic choriomeningitis virus: An emerging obstetric pathogen?
853
Lymphocytic choriomeningitis virus: Emerging fetal teratogen
854
Lymphocytic Interstitial Pneumonitis: An Unusual Presentation of X-Linked Hyper Ig M Syndrome
855
Lymphocytic leukemia presenting as acute Vogt–Koyanagi–Harada disease
856
Lymphocytic mediated alopecia: histological classification by pattern analysis
857
Lymphocytic myocarditis in childhood: Incidence and outcome following dual therapy immunosuppression
858
Lymphocytopathogenic activity in vitro correlates with high virulence in vivo for BVDV type 2 strains: Criteria for a third biotype of BVDV
859
Lymphocytosis without anemia in a patient presenting with anaphylactic shock
860
Lymphoedema of the eyelids
861
Lymphoedema, subcutaneous fibrosis and dysphagia:late presentation of recurrent breast carcinoma after 36 years
862
Lymphoedema-area-restricted Sweet syndrome during G-CSF treatment
863
Lymphœdème du membre supérieur après traitement du cancer du sein
864
Lymphœdème du membre supérieur après traitement du cancer du sein
865
Lymphœdème du membre supérieur après traitement du cancer du sein
866
Lymphœdème secondaire au traitement du cancer du sein : à propos d’une série de 98 cas
867
Lymphœdème secondaire au traitement du cancer du sein : à propos d’une série de 98 cas
868
Lymphoepithelial – Like Carcinoma with Papillary Transitional Cell Carcinoma of the Urinary Bladder Associated with Carcinoma in situ Changes of the Urothelium; A Case Report and Review of Literature
869
Lymphoepithelial carcinoma of the larynx
870
Lymphoepithelial cyst of the pancreas—evaluation with multidetector CT
871
Lymphoepithelioma-like carcinoma of the breast in the absence of Epstein-Barr virus
872
Lymphoepithelioma-like carcinoma of the breast: is it a distinct entity?: Clinicopathological evaluation of two cases and review of the literature
873
Lymphoepithelioma-Like Carcinoma of the Lung
874
Lymphogenous and hematogenous metastasis of thymic epithelial tumors
875
Lymphogranuloma venereum in the industrialised world
876
Lymphographic map of the breast
877
Lymphoid apoptosis in Edwardsiella tarda septicemia in tilapia, Oreochromis niloticus
878
Lymphoid Genes Expression in Mouse Embryonic Stem Cells with Differentiation on Feeder Free Condition
879
Lymphoid hypoplasia and somatic cloning
880
Lymphoid Leucosis and Coligranoluma in a Budgerigar (Melopsittacus undulatus)
881
Lymphoid neogenesis in chronic rejection: the murderer is in the house
882
Lymphoid Neo-organogenesis
883
Lymphoid neoplasms
884
Lymphoid precursors
885
Lymphoid progenitors and primary routes to becoming cells of the immune system
886
Lymphoid progenitors exhibit accelerated thymimic and marrow engraftment relative to stem cells
887
Lymphoid tissue reactions in rheumatoid arthritis
888
Lymphoid tumour of the ocular adnexa: a morphologic and genotypic tudy of 15 cae
889
Lymphokine activated killer cells from peripheral blood mononuclear cells of endometriosis of patients improve cytotoxicity to endometriosis cell culture
890
Lymphokine Expression in Granulomas of Schistosoma mansoni-Infected Mice
891
Lymphokine Expression Profile of Resting and Stimulated CD4+ CTL Clones Specific for the Glycoprotein of Vesicular Stomatitis Virus
892
Lymphokine Regulation of Activation-Induced Apoptosis in T Cells of IL-2 and IL-2Rβ Knockout Mice
893
Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
894
Lymphokine-Activated Killing by Human Intestinal Lymphocytes
895
Lymphokines modulate the growth and survival of thymic tumor cells containing a novel feline leukemia virus/Notch2 variant
896
Lymphokines modulate the growth and survival of thymic tumor cells containing a novel feline leukemia virus/Notch2 variant
897
Lymphoma induced in mice chronically exposed to very strong low-frequency electromagnetic field
898
Lymphoma infectious mononucleosis by Epstein-Barr virus: A case report
899
Lymphoma Masquerading as Tuberculosis of the Vertebra: Case Report and Discussion of Diagnosis
900
Lymphoma of base of The Tongue, Consideration to mycological examination along with immunohistochemistry: A Case report
901
Lymphoma of larynx presented with hoarseness: Case report
902
Lymphoma of the pituitary gland: An unusual presentation of central nervous system lymphoma in AIDS
903
Lymphoma of the tympanic membrane in acquired immunodeficiency syndrome
904
Lymphoma presenting as a large ulcerating small bowel lesion
905
Lymphoma presenting as parotid xanthogranulomatous sialadenitis
906
Lymphoma Prevalence Patterns in Uganda, 1969-2006
907
Lymphomas and reactive lymphoid lesions in HIV infection
908
Lymphomas in Iran
909
Lymphomatoid contact dermatitis caused by nickel
910
Lymphomatoid granulomatosis in a pediatric patient
911
Lymphomatou meningiti of the burkitt type preenting with multiple cranial neuropathie
912
Lymphome angiocentrique de la face : à propos de 2 cas
913
Lymphome cérébral primitif traité par méthotrexate à haute dose et irradiation de 20 Gy de lʹencéphale en totalité puis de 30 Gy dans un volume réduit
914
Lymphome cérébral primitif traité par méthotrexate à haute dose et irradiation de 20 Gy de lʹencéphale en totalité puis de 30 Gy dans un volume réduit
915
Lymphome choroïdien primitif traité par CyberKnife®
916
Lymphome choroïdien primitif traité par CyberKnife®
917
Lymphome cutané B à grandes cellules
918
Lymphome cutané B à grandes cellules
919
Lymphome de MALT du rectum : à propos d’un cas traité par irradiation
920
Lymphome du MALT orbitaire : revue de la littérature à propos d’un cas traité par irradiation exclusive
921
Lymphome du MALT orbitaire : revue de la littérature à propos d’un cas traité par irradiation exclusive
922
Lymphome du testicule. ةtude rétrospective multicentrique des centres de la fédération nationale des centres de lutte contre le cancer
923
Lymphome hodgkinien localisé de l’adulte en Tunisie : à propos de 114 cas
924
Lymphome hodgkinien localisé de l’adulte en Tunisie : à propos de 114 cas
925
Lymphome non hodgkinien de l’utérus. À propos de quatre cas et revue de la littérature
926
Lymphome non hodgkinien du cavum : expérience du service d’oncologie-radiothérapie de Constantine
927
Lymphome non hodgkinien du cavum : expérience du service d’oncologie-radiothérapie de Constantine
928
Lymphome non hodgkinien du cavum : résultats thérapeutiques et facteurs pronostiques
929
Lymphome non hodgkinien du cavum : résultats thérapeutiques et facteurs pronostiques
930
Lymphome non hodgkinien primitif du foie : à propos dʹun cas et revue de la littérature
931
Lymphome osseux primitif localisé : à propos de quatre cas
932
Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ?
933
Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ?
934
Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ?
935
Lymphomes B à grandes cellules de pronostic favorable traités par CHOP et irradiation
936
Lymphomes B à grandes cellules de pronostic favorable traités par CHOP et irradiation
937
Lymphomes cutanés en Tunisie: profil clinique et résultats thérapeutiques
938
Lymphomes cutanés traités par radiothérapie exclusive
939
Lymphomes non hodgkiniens primitifs du cavum : expérience de l’Institut national d’oncologie de Rabat au Maroc
940
Lymphomes non hodgkiniens primitifs du cavum : expérience de l’Institut national d’oncologie de Rabat au Maroc
941
Lymphomes non hodgkiniens primitifs du nasopharynx : à propos de 14 cas
942
Lymphomes non hodgkiniens primitifs du nasopharynx : à propos de 14 cas
943
Lymphomes non-hodgkiniens des tissus mous maxillofaciaux : à propos de deux cas et revue de la littérature
944
Lymphomes primitifs nasosinusiens. ہ propos de 25 cas
945
Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
946
Lymphopenia and poor performance status as major predictors for infections among residents in long-term care facilities (LTCFs): A prospective cohort study
947
Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival
948
Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease
949
Lymphoplasmacytic lymphoma/Waldenstrِm macroglobulinemia with inv(16)(p13q22) as a sole genetic abnormality
950
Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study
951
Lymphoproliferative disorders in Sjögrenʹs syndrome
952
lymphoproliferative malignancy in a treated case of carcinoma breast: A case report emphasizing the importance of PET-CT in cutaneous T cell lymphoma
953
Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats
954
Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines
955
Lymphoreticular diseases in Nigerians
956
Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
957
Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer
958
Lymphoscintigraphy In a Case of Recurrent Chylopericardium
959
Lymphoscintigraphy of the axilla with aspecific colloids and monoclonal antibodies
960
Lymphotoxin-α polymorphism and the risk of cervical cancer in Japanese subjects
961
Lymphovascular and Perineural Invasions Are Independently Associated with Advanced Colorectal Carcinoma
962
Lymphovascular Invasion Evaluation by the CD31 Expression in Gastric Adenocarcinoma
963
Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: Results of a multicenter study
964
Lynch revisited
965
Lynch revisited
966
Lynch revisited: New urbanism and theories of good city form
967
Lynchets in eastern Belgium — a geomorphic feature resulting from non-mechanised crop farming
968
Lynch-like Syndrome and its Molecular Approaches: A Brief Report and Literature Review
969
Lyndon factorization of sturmian words Original Research Article
970
Lyndon heaps: An analogue of Lyndon words in free partially commutative monoids Original Research Article
971
Lyndon words and Fibonacci numbers
972
Lyndon words, polylogarithms and the Riemann ζ function
973
Lyness-type equations in the third quardrant Original Research Article
974
Lyngbyacyclamides A and B, novel cytotoxic peptides from marine cyanobacteria Lyngbya sp.
975
Lynn Richard, Race Differences in Intelligence: An Evolutionary Analysis, Washington Summit Books, Augusta, GA (2005) ISBN 1-59368-020-1 318 pp., US$34.95.
976
Lynn Van der Wagen, Human Resource Management for Events. Managing the Event Workforce, Butterworth-Heinemann, Oxford (2007) ISBN 978-0-7506-6998-6 255 pp., £29.99.
977
Lynx reintroductions in fragmented landscapes of Germany: Projects with a future or misunderstood wildlife conservation? Original Research Article
978
Lynx: An unattended sensor system for detection of gamma-ray and neutron emissions from special nuclear materials
979
Lynx: An unattended sensor system for detection of gamma-ray and neutron emissions from special nuclear materials
980
Lynx1 Prevents Long-Term Potentiation Blockade and Reduction of Neuromodulator Expression Caused by Aβ1-42 and JNK Activation
981
Lyoluminescence and ESR correlation studies of trehalose dihydrate
982
Lyoluminescence and ESR measurements on alanine and sucrose dosimeters
983
Lyoluminescence characteristics of trehalose dihydrate
984
Lyoluminescence properties of γ-irradiated and Dy 3+ activated (K0.5 Na0.5)Cl phosphors for accidental radiation dosimetry
985
Lyondell may divest the Millennium TiO2 business
986
Lyondell to absorb Millennium
987
Lyophilization as a novel approach for preparation of water resistant HA fiber membranes by crosslinked with EDC
988
Lyophilization monophase solution technique for improvement of the solubility and dissolution of piroxicam
989
Lyophilization Process Effect Investigation on Quality Characteristics of Sugar used in Pharmaceutical Industry
990
Lyophilized Chitosan/xanthan Polyelectrolyte Complex Based Mucoadhesive Inserts for Nasal Delivery of Promethazine Hydrochloride
991
Lyophilized histidine investigated using X-ray photoelectron spectroscopy and cryogenics: Deprotonation in vacuum
992
Lyophilized wafers comprising carrageenan and pluronic acid for buccal drug delivery using model soluble and insoluble drugs
993
Lyophyllum sp. strain Karsten alleviates pH pressure in acid soil and enhances the survival of Variovorax paradoxus HB44 and other bacteria in the mycosphere
994
Lyophyllum sp. strain Karsten alleviates pH pressure in acid soil and enhances the survival of Variovorax paradoxus HB44 and other bacteria in the mycosphere
995
Lyotaphin treatment of methicillin-reitant taphylococcu aureu keratiti in the rabbit
996
Lyotard and Hegel: what is wrong with modernity and what is right with the philosophy of right
997
Lyotardʹs homeopathic indeterminacy: The medicinal sublime
998
Lyothermal synthesis of nanocrystalline BaSnO3 powders
999
Lyotropic aggregate of tripeptide derivatives within organic solvents: study on dynamic property of molecular assembling
1000
Lyotropic liquid crystal formation of polystyrene polymacromonomers in dichloromethane